Isolation and characterization of stable mutants ofStreptomyces peucetius defective in daunorubicin biosynthesis

Journal of Genetics
2001.0

Abstract

Daunorubicin and its derivative doxorubicin are antitumour anthracycline antibiotics produced by Streptomyces peucetius. In this study we report isolation of stable mutants of S. peucetius blocked in different steps of the daunorubicin biosynthesis pathway. Mutants were screened on the basis of colony colour since producer strains are distinctively coloured on agar plates. Different mutants showed accumulation of aklaviketone, epsilon-rhodomycinone, maggiemycin or 13-dihydrocarminomycin in their culture filtrates. These results indicate that the mutations in these isolates affect steps catalysed by dnrE (mutants SPAK and SPMAG), dnrS (SPFS and SPRHO) and doxA (SPDHC) gene products.

Knowledge Graph

Similar Paper

Isolation and characterization of stable mutants ofStreptomyces peucetius defective in daunorubicin biosynthesis
Journal of Genetics 2001.0
Streptomyces peucetius daunorubicin biosynthesis gene, dnrF: sequence and heterologous expression
Microbiology 1995.0
Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization.
The Journal of Antibiotics 1992.0
Cloning and characterization of the Streptomyces peucetius dnrQS genes encoding a daunosamine biosynthesis enzyme and a glycosyl transferase involved in daunorubicin biosynthesis
Journal of Bacteriology 1995.0
Microbial conversion of anthracyclinones to daunomycin by blocked mutants of Streptomyces coeruleorubidus.
The Journal of Antibiotics 1980.0
Microbial conversion of anthracyclinones to daunomycin by blocked mutants of Streptomyces coeruleorubidus.
The Journal of Antibiotics 1980.0
Production of the antitumor drug epirubicin (4′-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius
Nature Biotechnology 1998.0
Production of the antitumor drug epirubicin (4′-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius
Nature Biotechnology 1998.0
Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.
The Journal of Antibiotics 1993.0
13-Deoxycarminomycin, a New Biosynthetic Anthracycline
Journal of Natural Products 1985.0